Sameer Melinkeri
Impact in
-
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 6
- COVID-19 and healthcare impacts 3
-
- Antifungal resistance and susceptibility 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Lalita Limaye (7 shared papers)Vaijayanti Kale (7 shared papers)Sunil Dabadghao (2 shared papers)Ruchi Gupta (1 shared paper)Saroj Kanta Mishra (1 shared paper)Joseph Philip (1 shared paper)Vikram Mathews (3 shared papers)Manas Kumar Santra (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Stem Cell Research (2 papers)Transfusion (1 paper)Stem Cell Research & Therapy (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- IndiaUnited States
In The Last Decade
Sameer Melinkeri
23 papers receiving 221 citations
Peers
Comparison fields: 5 of 55
- Hematology 57
- Immunology 83
- Oncology 58
- Genetics 17
- Biochemistry 10
Countries citing papers authored by Sameer Melinkeri
This map shows the geographic impact of Sameer Melinkeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Melinkeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Melinkeri more than expected).
Fields of papers citing papers by Sameer Melinkeri
This network shows the impact of papers produced by Sameer Melinkeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Melinkeri. The network helps show where Sameer Melinkeri may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Melinkeri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 58 | |
| 2 | 2020 | 25 | |
| 3 | 2002 | 22 | |
| 4 | 2013 | 18 | |
| 5 | 2001 | 14 | |
| 6 | 2018 | 12 | |
| 7 | 2020 | 12 | |
| 8 | 2019 | 12 | |
| 9 | 2017 | 11 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2017 | 4 | |
| 15 | 2023 | 4 | |
| 16 | Epidemiology, Pathogenesis and Diagnosis of Aplastic Anaemia. | 2015 | 4 |
| 17 | 2020 | 2 | |
| 18 | 2024 | 2 | |
| 19 | Immune thrombocytopenia (ITP): a rare association of lymph node tuberculosis. | 2014 | 2 |
| 20 | 2025 | 1 |
About Sameer Melinkeri
Sameer Melinkeri is a scholar working on Oncology, Infectious Diseases, Hematology, Immunology and Physiology, having authored 25 papers that have together received 230 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (3 papers), Platelet Disorders and Treatments (3 papers), Immunotherapy and Immune Responses (3 papers), COVID-19 and healthcare impacts (3 papers), Antifungal resistance and susceptibility (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Blood groups and transfusion (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Hematology (57 citations), Immunology (83 citations), Oncology (58 citations), Genetics (17 citations) and Biochemistry (10 citations). Sameer Melinkeri has collaborated with scholars based in India and United States. Frequent co-authors include Lalita Limaye, Vaijayanti Kale, Sunil Dabadghao, Ruchi Gupta, Saroj Kanta Mishra, Joseph Philip, Vikram Mathews, Manas Kumar Santra, Rayaz Ahmed and Subhal Dixit. Their work appears in journals such as Frontiers in Oncology, Stem Cell Research, Transfusion, Stem Cell Research & Therapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.